Polycystic Ovary Syndrome and the Internet of Things: A Scoping Review
- PMID: 39201229
- PMCID: PMC11354210
- DOI: 10.3390/healthcare12161671
Polycystic Ovary Syndrome and the Internet of Things: A Scoping Review
Abstract
Polycystic ovary syndrome (PCOS) is a prevalent endocrine disorder impacting women's health and quality of life. This scoping review explores the use of the Internet of Things (IoT) in PCOS management. Results were grouped into six domains of the IoT: mobile apps, social media, wearables, machine learning, websites, and phone-based. A further domain was created to capture participants' perspectives on using the IoT in PCOS management. Mobile apps appear to be useful for menstrual cycle tracking, symptom recording, and education. Despite concerns regarding the quality and reliability of social media content, these platforms may play an important role in disseminating PCOS-related information. Wearables facilitate detailed symptom monitoring and improve communication with healthcare providers. Machine learning algorithms show promising results in PCOS diagnosis accuracy, risk prediction, and app development. Although abundant, PCOS-related content on websites may lack quality and cultural considerations. While patients express concerns about online misinformation, they consider online forums valuable for peer connection. Using text messages and phone calls to provide feedback and support to PCOS patients may help them improve lifestyle behaviors and self-management skills. Advancing evidence-based, culturally sensitive, and accessible IoT solutions can enhance their potential to transform PCOS care, address misinformation, and empower women to better manage their symptoms.
Keywords: Internet of Things (IoT); artificial intelligence (AI); machine learning; mobile app; polycystic ovary syndrome (PCOS); social media; wearable.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures
Similar articles
-
Ask PCOS: Identifying Need to Inform Evidence-Based App Development for Polycystic Ovary Syndrome.Semin Reprod Med. 2018 Jan;36(1):59-65. doi: 10.1055/s-0038-1667187. Epub 2018 Sep 6. Semin Reprod Med. 2018. PMID: 30189452
-
Current Use and Discrepancies in the Adoption of Health-Related Internet of Things and Apps Among Working Women in Japan: Large-Scale, Internet-Based, Cross-Sectional Survey.JMIR Public Health Surveill. 2024 Jul 31;10:e51537. doi: 10.2196/51537. JMIR Public Health Surveill. 2024. PMID: 39083338 Free PMC article.
-
"Less Than A Wife": A Study of Polycystic Ovary Syndrome Content in Teen and Women's Digital Magazines.J Med Internet Res. 2016 Jun 2;18(6):e89. doi: 10.2196/jmir.5417. J Med Internet Res. 2016. PMID: 27255809 Free PMC article.
-
Unveiling the Role of Artificial Intelligence (AI) in Polycystic Ovary Syndrome (PCOS) Diagnosis: A Comprehensive Review.Reprod Sci. 2024 Oct;31(10):2901-2915. doi: 10.1007/s43032-024-01615-7. Epub 2024 Jun 21. Reprod Sci. 2024. PMID: 38907128 Review.
-
Direct economic burden of mental health disorders associated with polycystic ovary syndrome: Systematic review and meta-analysis.Elife. 2023 Aug 3;12:e85338. doi: 10.7554/eLife.85338. Elife. 2023. PMID: 37534878 Free PMC article.
Cited by
-
Scientific Progress in Polycystic Ovary Syndrome: Little by Little.J Clin Med. 2025 Jan 1;14(1):200. doi: 10.3390/jcm14010200. J Clin Med. 2025. PMID: 39797283 Free PMC article.
-
Availability and Use of Digital Technology Among Women With Polycystic Ovary Syndrome: Scoping Review.JMIR Infodemiology. 2025 Jun 12;5:e68469. doi: 10.2196/68469. JMIR Infodemiology. 2025. PMID: 40505084 Free PMC article.
-
Assessing quality, reliability and accuracy of polycystic ovary syndrome-related content on TikTok: A video-based cross-sectional analysis.Int J Gynaecol Obstet. 2025 Jul;170(1):274-283. doi: 10.1002/ijgo.70007. Epub 2025 Feb 10. Int J Gynaecol Obstet. 2025. PMID: 39927850 Free PMC article.
References
-
- Teede H.J., Tay C.T., Laven J., Dokras A., Moran L.J., Piltonen T.T., Costello M.F., Boivin J., Redman L.M., Boyle J.A., et al. Recommendations from the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome. Hum. Reprod. 2023;38:1655–1679. doi: 10.1093/humrep/dead156. - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources